市場調査レポート
商品コード
1452594

北米の家禽診断:2030年までの市場予測 - 地域別分析 - 検査タイプ別、疾患別

North America Poultry Diagnostic Market Forecast to 2030 - Regional Analysis - By Test Type and Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others)

出版日: | 発行: The Insight Partners | ページ情報: 英文 77 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
北米の家禽診断:2030年までの市場予測 - 地域別分析 - 検査タイプ別、疾患別
出版日: 2024年01月15日
発行: The Insight Partners
ページ情報: 英文 77 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の家禽診断市場は、2022年の1億1,889万米ドルから2030年には2億5,367万米ドルに成長すると予測されています。2022年から2030年までのCAGRは9.9%と推定されます。

農場サイド診断家禽プラットフォームが北米の家禽診断市場を牽引

現在では、家禽のウイルスや細菌性病原体を検査することで、疾病の蔓延を抑制するために、感染率の高い農場現場にシンプルな農場側分子診断プラットフォームと補完的な監視ソフトウェアが設置されています。また、養鶏業界チームは、世界保健機関(WHO)のガイドラインを遵守した、ポータブルでバッテリー駆動のスタンドアローン診断プラットフォームの開発に短期間で成功し、これらの装置を農場のどこでも操作できるようにすることで、実験室の構造や訓練を受けた人員、追加設備の必要性を排除することができます。また、本装置のコストは、市販されている同等の装置よりも95%低く、同等の基準を示すゴールドスタンダード装置との比較検証済みです。したがって、このような農場サイドでの家禽疾病診断プラットフォームの導入は、早期発見と封じ込めを可能にすることで、農家が感染症、抗菌剤耐性(AMR)、人獣共通感染症の蔓延を抑えるのに役立ちます。

北米の家禽診断市場概要

北米の家禽診断市場は米国、カナダ、メキシコに区分されます。2022年、米国はこの地域で最大の市場シェアを占め、家禽由来製品の消費増加や食品安全に関する消費者の意識の高まりにより、予測期間中もその優位性が続くと予想されます。さらに、国連食糧農業機関(UNFAO)が発表した統計によると、2022年には北米で鶏卵と鶏の生産が増加しました。

北米の家禽診断市場の収益と2030年までの予測(金額)

北米の家禽診断市場のセグメンテーション

北米の家禽診断市場は、検査タイプ、疾患、国に区分されます。

検査タイプ別では、北米の家禽診断市場は酵素結合免疫吸着測定法(ELISA)検査、ポリメラーゼ連鎖反応(PCR)検査、血球凝集阻害(hi)検査、その他に区分されます。2022年の北米の家禽診断市場では、酵素結合免疫吸着測定法(ELISA)検査セグメントが最大のシェアを占めました。

疾病別では、北米の家禽診断市場は鳥インフルエンザ、伝染性気管支炎、鳥サルモネラ症、ニューカッスル病、鳥マイコプラズマ症、その他に区分されます。2022年の北米の家禽診断市場では、鳥インフルエンザ分野が最大のシェアを占めています。

国別に見ると、北米の家禽診断市場は米国、カナダ、メキシコに区分されます。2022年の北米の家禽診断市場は米国が支配的でした。

Thermo Fisher Scientific Inc、Idexx Laboratories Inc、Qiagen NV、Eurofins Scientific SE、Boehringer Ingelheim International GmbH、Zoetis Inc、BioCheck BV、Bioneer Corpは、北米の家禽診断市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米の家禽診断市場- 主要産業力学

  • 市場促進要因
    • 人獣共通感染症患者の増加
    • 技術の進歩
  • 市場抑制要因
    • 不十分な家禽福祉対策
  • 市場機会
    • 政府の支援と取り組み
  • 市場動向
    • 農場サイド診断家禽プラットフォーム
  • 影響分析

第5章 北米の家禽診断市場- 市場分析

  • 北米の家禽診断市場収益、2022年~2030年

第6章 北米の家禽診断市場:収益と2030年までの予測 - 検査タイプ別

  • 市場収益シェア(%)、2022年および2030年
  • 酵素結合免疫吸着測定法(ELISA)検査
  • ポリメラーゼ連鎖反応(PCR)検査
  • 血球凝集阻害(HI)検査
  • その他

第7章 北米の家禽診断市場:収益と2030年までの予測 - 疾患別

  • 市場収益シェア(%)、2022年および2030年
  • 鳥インフルエンザ
  • 感染性気管支炎
  • サルモネラ症
  • ニューカッスル病
  • 鳥マイコプラズマ症
  • その他

第8章 北米の家禽診断市場:収益と2030年までの予測 - 国別分析

  • 米国
  • カナダ
  • メキシコ

第9章 北米の家禽診断市場-業界情勢

  • 北米の家禽診断市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第10章 企業プロファイル

  • Thermo Fisher Scientific Inc
  • Idexx Laboratories Inc
  • Qiagen NV
  • Eurofins Scientific SE
  • Boehringer Ingelheim International GmbH
  • Zoetis Inc
  • BioCheck BV
  • Bioneer Corp

第11章 付録

図表

List Of Tables

  • Table 1. North America Poultry Diagnostics Market Segmentation
  • Table 2. US Diagnostics Market, by Test Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 3. US Diagnostics Market, by Disease - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 4. Canada Poultry Diagnostics Market, by Test Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 5. Canada Poultry Diagnostics Market, by Disease - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 6. Mexico Poultry Diagnostics Market, by Test Type - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 7. Mexico Poultry Diagnostics Market, by Disease - Revenue and Forecast to 2030 (US$ Thousand)
  • Table 8. Recent Inorganic Growth Strategies in the North America Poultry Diagnostics Market
  • Table 9. Recent Organic Growth Strategies in the North America Poultry Diagnostics Market
  • Table 10. Glossary of Terms, North America Poultry Diagnostics Market

List Of Figures

  • Figure 1. North America Poultry Diagnostics Market Segmentation, By Country
  • Figure 2. North America Poultry Diagnostics Market: Key Industry Dynamics
  • Figure 3. North America Poultry Diagnostics Market: Impact Analysis of Drivers and Restraints
  • Figure 4. North America Poultry Diagnostics Market Revenue (US$ Thousand), 2020 - 2030
  • Figure 5. North America Poultry Diagnostics Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 6. Enzyme-Linked Immunosorbent Assay (ELISA) Tests: North America Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 7. Polymerase Chain Reaction (PCR) Tests: North America Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 8. Hemagglutination-Inhibition (HI): North America Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 9. Others: North America Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 10. North America Poultry Diagnostics Market Revenue Share, by Disease 2022 & 2030 (%)
  • Figure 11. Avian Influenza: North America Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 12. Infectious Bronchitis: North America Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 13. Avian Salmonellosis: North America Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 14. Newcastle Disease: North America Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 15. Avian Influenza: North America Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 16. Others: North America Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 17. North America Poultry Diagnostics Market, by Key Country - Revenue (2022) (US$ Thousand)
  • Figure 18. North America Poultry Diagnostics Market, by Country, 2022 & 2030 (%)
  • Figure 19. US Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 20. Canada Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 21. Mexico Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
  • Figure 22. Growth Strategies in the North America Poultry Diagnostics Market
目次
Product Code: BMIRE00029275

The North America poultry diagnostic market is expected to grow from US$ 118.89 million in 2022 to US$ 253.67 million by 2030. It is estimated to grow at a CAGR of 9.9% from 2022 to 2030.

Farm-Side Diagnostic Poultry Platform Fuel North America Poultry Diagnostic Market

Nowadays, a simple farm-side molecular diagnostic platform and complementary surveillance software are installed at the farm site with a high infection rate to curb the spread of disease by test poultry animals for viral and bacterial pathogens. Also, within a short span the poultry industry team can successfully develop a portable, battery-powered, stand-alone diagnostic platform abiding by World Health Organization (WHO) guidelines to ensure that these devices can be operated anywhere on the farm, eliminating the need for laboratory structure, trained personnel, and additional equipment. Also, the cost of the device is 95% lower than comparable commercially available devices and validated against gold standard devices showing equivalent standards. Therefore, implementation of such farm-side poultry disease diagnostic platforms would help farmers keep a check on the spread of infectious disease, antimicrobial resistance (AMR), and zoonotic pathogens by enabling early detection and containment.

North America Poultry Diagnostic Market Overview

The North America poultry diagnostics market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share in this region and is expected to continue its dominance during the forecast period due to the increasing consumption of poultry-derived products and growing consumer awareness regarding food safety. Moreover, as per the statistics published by the United Nations Food and Agriculture Organization (UNFAO), in 2022, there was an increase in the production of eggs and hens in North America.

North America Poultry Diagnostic Market Revenue and Forecast to 2030 (US$ Million)

North America poultry diagnostic market Segmentation

The North America poultry diagnostic market is segmented into test type, disease, and country.

Based on test type, the North America poultry diagnostic market is segmented into enzyme-linked immunosorbent assay (ELISA) tests, polymerase chain reaction (PCR) tests, hemagglutination-inhibition (hi), and others. The enzyme-linked immunosorbent assay (ELISA) tests segment held the largest share of the North America poultry diagnostic market in 2022.

Based on disease, the North America poultry diagnostic market is segmented into avian influenza, infectious bronchitis, avian salmonellosis, Newcastle disease, avian mycoplasmosis, and others. The avian influenza segment held the largest share of the North America poultry diagnostic market in 2022.

Based on country, the North America poultry diagnostic market is segmented into the US, Canada, and Mexico. The US dominated the North America poultry diagnostic market in 2022.

Thermo Fisher Scientific Inc, Idexx Laboratories Inc, Qiagen NV, Eurofins Scientific SE, Boehringer Ingelheim International GmbH, Zoetis Inc, BioCheck BV, and Bioneer Corp are some of the leading companies operating in the North America poultry diagnostic market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Poultry Diagnostics Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Zoonotic Disease Cases
    • 4.1.2 Technological Advancements
  • 4.2 Market Restraint
    • 4.2.1 Insufficient Welfare Measures for Poultry
  • 4.3 Market Opportunity
    • 4.3.1 Government Support and Initiatives
  • 4.4 Market Trends
    • 4.4.1 Farm-Side Diagnostic Poultry Platform
  • 4.5 Impact Analysis

5. North America Poultry Diagnostics Market - Market Analysis

  • 5.1 North America Poultry Diagnostics Market Revenue (US$ Thousand), 2022 - 2030

6. North America Poultry Diagnostics Market - Revenue and Forecast to 2030 - by Test Type

  • 6.1 Overview
  • 6.2 North America Poultry Diagnostics Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 6.3 Enzyme-Linked Immunosorbent Assay (ELISA) Tests
    • 6.3.1 Overview
    • 6.3.2 Enzyme-Linked Immunosorbent Assay (ELISA) Tests: North America Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.4 Polymerase Chain Reaction (PCR) Tests
    • 6.4.1 Overview
    • 6.4.2 Polymerase Chain Reaction (PCR) Tests: North America Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.5 Hemagglutination-Inhibition (HI)
    • 6.5.1 Overview
    • 6.5.2 Hemagglutination-Inhibition (HI): North America Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 6.6 Others
    • 6.6.1 Overview
    • 6.6.2 Others: North America Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)

7. North America Poultry Diagnostics Market - Revenue and Forecast to 2030 - by Disease

  • 7.1 Overview
  • 7.2 North America Poultry Diagnostics Market Revenue Share, by Disease 2022 & 2030 (%)
  • 7.3 Avian Influenza
    • 7.3.1 Overview
    • 7.3.2 Avian Influenza: North America Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 7.4 Infectious Bronchitis
    • 7.4.1 Overview
    • 7.4.2 Infectious Bronchitis: North America Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 7.5 Avian Salmonellosis
    • 7.5.1 Overview
    • 7.5.2 Avian Salmonellosis: North America Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 7.6 Newcastle Disease
    • 7.6.1 Overview
    • 7.6.2 Newcastle Disease: North America Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 7.7 Avian Mycoplasmosis
    • 7.7.1 Overview
    • 7.7.2 Avian Mycoplasmosis: North America Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: North America Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)

8. North America Poultry Diagnostics Market - Revenue and Forecast to 2030 - Country Analysis

  • 8.1 North America Poultry Diagnostics Market
    • 8.1.1 Overview
    • 8.1.2 North America Poultry Diagnostics Market, by Country, 2022 & 2030 (%)
      • 8.1.2.1 US Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
        • 8.1.2.1.1 Overview
        • 8.1.2.1.2 US Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
        • 8.1.2.1.3 US Poultry Diagnostics Market, by Test Type, 2020-2030 (US$ Thousand)
        • 8.1.2.1.4 US Poultry Diagnostics Market, by Disease, 2020-2030 (US$ Thousand)
      • 8.1.2.2 Canada Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
        • 8.1.2.2.1 Overview
        • 8.1.2.2.2 Canada Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
        • 8.1.2.2.3 Canada Poultry Diagnostics Market, by Test Type, 2020-2030 (US$ Thousand)
        • 8.1.2.2.4 Canada Poultry Diagnostics Market, by Disease, 2020-2030 (US$ Thousand)
      • 8.1.2.3 Mexico Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
        • 8.1.2.3.1 Overview
        • 8.1.2.3.2 Mexico Poultry Diagnostics Market - Revenue and Forecast to 2030 (US$ Thousand)
        • 8.1.2.3.3 Mexico Poultry Diagnostics Market, by Test Type, 2020-2030 (US$ Thousand)
        • 8.1.2.3.4 Mexico Poultry Diagnostics Market, by Disease, 2020-2030 (US$ Thousand)

9. North America Poultry Diagnostics Market-Industry Landscape

  • 9.1 Overview
  • 9.2 Growth Strategies in the North America Poultry Diagnostics Market
  • 9.3 Inorganic Growth Strategies
    • 9.3.1 Overview
  • 9.4 Organic Growth Strategies
    • 9.4.1 Overview

10. Company Profiles

  • 10.1 Thermo Fisher Scientific Inc
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Idexx Laboratories Inc
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Qiagen NV
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Eurofins Scientific SE
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Boehringer Ingelheim International GmbH
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Zoetis Inc
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 BioCheck BV
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Bioneer Corp
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments

11. Appendix

  • 11.1 About Us
  • 11.2 Glossary of Terms